Supernus Pharmaceuticals, Inc. (SUPN)
42.67
+0.53
(+1.26%)
USD |
NASDAQ |
Oct 09, 16:00
42.67
0.00 (0.00%)
After-Hours: 18:53
Supernus Pharmaceuticals Total Return Level : 42.14 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 42.14 |
| October 07, 2026 | 43.05 |
| October 06, 2026 | 42.83 |
| October 05, 2026 | 42.76 |
| October 02, 2026 | 42.38 |
| October 01, 2026 | 42.18 |
| September 30, 2026 | 43.04 |
| September 29, 2026 | 43.97 |
| September 28, 2026 | 44.60 |
| September 25, 2026 | 42.66 |
| September 24, 2026 | 43.29 |
| September 23, 2026 | 43.39 |
| September 22, 2026 | 43.75 |
| September 21, 2026 | 42.78 |
| September 18, 2026 | 42.00 |
| September 17, 2026 | 42.92 |
| September 16, 2026 | 41.38 |
| September 15, 2026 | 41.28 |
| September 14, 2026 | 41.49 |
| September 11, 2026 | 41.64 |
| September 10, 2026 | 41.69 |
| September 09, 2026 | 42.07 |
| September 08, 2026 | 42.43 |
| September 04, 2026 | 43.53 |
| September 03, 2026 | 43.97 |
| Date | Value |
|---|---|
| September 02, 2026 | 44.03 |
| September 01, 2026 | 43.74 |
| August 31, 2026 | 44.21 |
| August 28, 2026 | 43.73 |
| August 27, 2026 | 44.19 |
| August 26, 2026 | 44.88 |
| August 25, 2026 | 45.36 |
| August 24, 2026 | 45.11 |
| August 21, 2026 | 45.85 |
| August 20, 2026 | 47.45 |
| August 19, 2026 | 48.54 |
| August 18, 2026 | 49.03 |
| August 17, 2026 | 48.27 |
| August 14, 2026 | 48.27 |
| August 13, 2026 | 47.15 |
| August 12, 2026 | 47.87 |
| August 11, 2026 | 46.88 |
| August 10, 2026 | 47.07 |
| August 07, 2026 | 47.64 |
| August 06, 2026 | 46.76 |
| August 05, 2026 | 46.91 |
| August 04, 2026 | 43.25 |
| August 03, 2026 | 46.00 |
| July 31, 2026 | 44.63 |
| July 30, 2026 | 45.61 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Indivior Pharmaceuticals, Inc. | 36.87 |
| Prestige Consumer Healthcare, Inc. | 47.87 |
| Pfizer Inc. | 93.06 |
| Amphastar Pharmaceuticals, Inc. | 25.81 |
| Bristol Myers Squibb Co. | 225.98 |